These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 1950544

  • 1. Circumvention of drug resistance in cisplatin-resistant sublines of the human squamous carcinoma cell line HLac 79 in vitro and in vivo.
    Bier H.
    Acta Otolaryngol; 1991; 111(4):797-806. PubMed ID: 1950544
    [Abstract] [Full Text] [Related]

  • 2. [Increasing chemosensitivity to cisplatin by glutathione depletion with buthionine sulfoximine. In vitro and in vivo studies with a human squamous cell cancer line].
    Bier H.
    Laryngorhinootologie; 1990 Jan; 69(1):16-20. PubMed ID: 2310456
    [Abstract] [Full Text] [Related]

  • 3. Establishment and characterization of cisplatin-resistant sublines of the human squamous carcinoma cell line HLac 79.
    Bier H, Bergler W, Mickisch G, Wesch H, Ganzer U.
    Acta Otolaryngol; 1990 Jan; 110(5-6):466-73. PubMed ID: 2284922
    [Abstract] [Full Text] [Related]

  • 4. Effect of buthionine sulfoximine on PtII and PtIV drug accumulation and the formation of glutathione conjugates in human ovarian-carcinoma cell lines.
    Mistry P, Loh SY, Kelland LR, Harrap KR.
    Int J Cancer; 1993 Nov 11; 55(5):848-56. PubMed ID: 8244583
    [Abstract] [Full Text] [Related]

  • 5. Relationship of cellular glutathione to the cytotoxicity and resistance of seven platinum compounds.
    Meijer C, Mulder NH, Timmer-Bosscha H, Sluiter WJ, Meersma GJ, de Vries EG.
    Cancer Res; 1992 Dec 15; 52(24):6885-9. PubMed ID: 1458477
    [Abstract] [Full Text] [Related]

  • 6. The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line.
    Meijer C, Mulder NH, Hospers GA, Uges DR, de Vries EG.
    Br J Cancer; 1990 Jul 15; 62(1):72-7. PubMed ID: 2390486
    [Abstract] [Full Text] [Related]

  • 7. Modulation of cisplatin resistance in acquired-resistant nonsmall cell lung cancer cells.
    Lai SL, Hwang J, Perng RP, Whang-Peng J.
    Oncol Res; 1995 Jul 15; 7(1):31-8. PubMed ID: 7549042
    [Abstract] [Full Text] [Related]

  • 8. Enhancement of antitumor activity of cisplatin on human gastric cancer cells in vitro and in vivo by buthionine sulfoximine.
    Saikawa Y, Kubota T, Kuo TH, Furukawa T, Tanino H, Watanabe M, Ishibiki K, Kitajima M.
    Jpn J Cancer Res; 1993 Jul 15; 84(7):787-93. PubMed ID: 8370654
    [Abstract] [Full Text] [Related]

  • 9. The effects of cyclosporin A on the lysis of ovarian cancer cells by cisplatin or adriamycin.
    Mutch DG, Herzog TJ, Chen CA, Collins JL.
    Gynecol Oncol; 1992 Oct 15; 47(1):28-33. PubMed ID: 1427396
    [Abstract] [Full Text] [Related]

  • 10. Augmentation of cisplatin (DDP) cytotoxicity in vivo by DL-buthionine sulfoximine (BSO) in DDP-sensitive and-resistant rat ovarian tumors and its relation to DNA interstrand cross links.
    Chen G, Zeller WJ.
    Anticancer Res; 1991 Oct 15; 11(6):2231-7. PubMed ID: 1776864
    [Abstract] [Full Text] [Related]

  • 11. Enhanced melphalan cytotoxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathione.
    Ozols RF, Louie KG, Plowman J, Behrens BC, Fine RL, Dykes D, Hamilton TC.
    Biochem Pharmacol; 1987 Jan 01; 36(1):147-53. PubMed ID: 3801051
    [Abstract] [Full Text] [Related]

  • 12. Combination of cyclosporin A and buthionine sulfoximine (BSO) as a pharmacological strategy for circumvention of multidrug resistance in small cell lung cancer cell lines selected for resistance to doxorubicin.
    Larsson R, Bergh J, Nygren P.
    Anticancer Res; 1991 Jan 01; 11(1):455-9. PubMed ID: 1850223
    [Abstract] [Full Text] [Related]

  • 13. [Potentiation of cisplatin sensitivity of cisplatin-resistant human ovarian cancer cell lines by L-buthionine-S,R-sulfoximine].
    Kudoh K, Kita T, Hirata J, Ishii K, Hiramatsu H, Kikuchi Y, Nagata I.
    Nihon Sanka Fujinka Gakkai Zasshi; 1994 Jun 01; 46(6):525-32. PubMed ID: 8040625
    [Abstract] [Full Text] [Related]

  • 14. Effect of glutathione on DNA repair in cisplatin-resistant human ovarian cancer cell lines.
    Lai GM, Ozols RF, Young RC, Hamilton TC.
    J Natl Cancer Inst; 1989 Apr 05; 81(7):535-9. PubMed ID: 2493524
    [Abstract] [Full Text] [Related]

  • 15. Combined effects of buthionine sulfoximine and cepharanthine on cytotoxic activity of doxorubicin to multidrug-resistant cells.
    Kisara S, Furusawa S, Murata R, Ogata M, Hikichi N, Takayanagi Y, Sasaki K.
    Oncol Res; 1995 Apr 05; 7(3-4):191-200. PubMed ID: 8555653
    [Abstract] [Full Text] [Related]

  • 16. Overcoming tumor necrosis factor-alpha resistance of human renal and ovarian carcinoma cells by combination treatment with buthionine sulfoximine and tumor necrosis factor-alpha. Role of tumor necrosis factor-alpha mRNA down-regulation in tumor cell sensitization.
    Mizutani Y, Yoshida O.
    Cancer; 1994 Feb 01; 73(3):730-7. PubMed ID: 8299097
    [Abstract] [Full Text] [Related]

  • 17. Effect of buthionine sulfoximine on toxicity of verapamil and doxorubicin to multidrug resistant cells and to mice.
    Ford JM, Yang JM, Hait WN.
    Cancer Res; 1991 Jan 01; 51(1):67-72. PubMed ID: 1988108
    [Abstract] [Full Text] [Related]

  • 18. Cytotoxicity of antitumor platinum complexes with L-buthionine-(R,S)-sulfoximine and/or etanidazole in human carcinoma cell lines sensitive and resistant to cisplatin.
    Brooks SE, Korbut TT, Dupuis NP, Holden SA, Teicher BA.
    Cancer Chemother Pharmacol; 1995 Jan 01; 36(5):431-8. PubMed ID: 7634385
    [Abstract] [Full Text] [Related]

  • 19. Schedule-dependent reversion of acquired cisplatin resistance by 5-fluorouracil in a newly established cisplatin-resistant HST-1 human squamous carcinoma cell line.
    Esaki T, Nakano S, Masumoto N, Fujishima H, Niho Y.
    Int J Cancer; 1996 Feb 08; 65(4):479-84. PubMed ID: 8621231
    [Abstract] [Full Text] [Related]

  • 20. Mechanism of cross-resistance to cisplatin in a mitomycin C-resistant human bladder cancer cell line.
    Singh SV, Xu BH, Jani JP, Emerson EO, Backes MG, Rihn C, Scalamogna D, Stemmler N, Specht S, Blanock K.
    Int J Cancer; 1995 May 04; 61(3):431-6. PubMed ID: 7729958
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.